Equities

EssilorLuxottica SA

0OMK:LSE

EssilorLuxottica SA

  • Price (EUR)255.35
  • Today's Change-2.70 / -1.05%
  • Shares traded57.61k
  • 1 Year change-6.00%
  • Beta0.9623
Data delayed at least 20 minutes, as of Feb 06 2026 16:28 GMT.
More ▼

Profile data is unavailable for this security.

About the company

EssilorLuxottica SA is a France-based ophthalmic company. The Company designs, distributes, manufactures, and markets a range of lenses, frames, and sunglasses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, which includes corrective lenses, optical instruments intended for opticians and optometrists; Equipment, which includes machines and consumables used by plants and prescription laboratories, and Sunglasses & Readers, which encompasses non-prescription reading glasses and non-prescription sunglasses. EssilorLuxottica's assets include recognized brands, such as Ray-Ban and Oakley for eyewear, Varilux and Transitions for ophthalmic optical technologies, and Sunglass Hut and Lenscrafters for international distribution networks.

  • Revenue in EUR (TTM)27.24bn
  • Net income in EUR2.38bn
  • Incorporated1993
  • Employees200.08k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		0OMK:LSE since
announced		Transaction
value
Signifeye NvAnnounced12 Dec 202512 Dec 2025Announced-10.37%--
Automation & Robotics SADeal completed04 Aug 202504 Aug 2025Deal completed0.02%--
PUcore Co Ltd-Optical Materials DivisionDeal completed21 Jul 202521 Jul 2025Deal completed4.74%14.22m
A-Look Eyewear Sdn BhdDeal completed05 Jun 202505 Jun 2025Deal completed4.69%--
Owl Eyewear Sdn BhdDeal completed05 Jun 202505 Jun 2025Deal completed4.69%--
Data delayed at least 20 minutes, as of Feb 06 2026 16:28 GMT.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.